[18F] 3-deoxy-3′-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-d-glucose positron emission tomography in the workup of suspicious central focal lesions?
Open Access
- 30 April 2004
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 127 (4) , 1093-1099
- https://doi.org/10.1016/j.jtcvs.2003.09.003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinomaCancer, 2001
- Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren1 - Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000 -Pneumologie, 2001
- Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass LesionsJAMA, 2001
- Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective StudyJournal of Clinical Oncology, 2001
- Non-Small Cell Lung Cancer: FDG PET for Nodal Staging in Patients with Stage I DiseaseRadiology, 2000
- How Useful is Positron Emission Tomography for Lymphnode Staging in Non-Small-Cell Lung Cancer?The Thoracic and Cardiovascular Surgeon, 2000
- Prognostic Value of Thoracic FDG PET Imaging After Treatment for Non-Small Cell Lung CancerAmerican Journal of Roentgenology, 2000
- Prognostic Importance of the Standardized Uptake Value on 18F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 CasesJournal of Clinical Oncology, 1999
- Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET)Thorax, 1997
- Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996